Ionising radiation

Soft tissue sarcoma - Ionising radiation Factor

Last reviewed for CCPS 20 August 2008.

Investigative Documents

Claimant Report - Exposure to Ionising Radiation from Alpha Particles [CR9264]

Preliminary questions [36212]

36217

there is some evidence that ionising radiation may be a factor in the development of the condition under consideration.

36218 the veteran has received ionising radiation from internal deposition of a substance which emits alpha particles at some time.

36219

the veteran has received ionising radiation to the site affected by soft tissue sarcoma from internal deposition of a substance which emits alpha particles at some time.

36214 — the veteran has established the causal connection between ionising radiation and VEA service for the clinical onset of soft tissue sarcoma.

36215 — the veteran has established the causal connection between ionising radiation and operational service for the clinical onset of soft tissue sarcoma.

or

36216 — the veteran has established the causal connection between ionising radiation and eligible service for the clinical onset of soft tissue sarcoma.

Clinical onset and operational service [36215]

36220

on operational service, the veteran received a cumulative equivalent dose of at least 0.05 Sievert of ionising radiation to the site affected by soft tissue sarcoma from internal deposition of a substance which emits alpha particles.

36222

on operational service, the veteran received a cumulative equivalent dose of at least 0.05 Sievert of ionising radiation to the site affected by soft tissue sarcoma from internal deposition of a substance which emits alpha particles at least two years before the clinical onset of the condition under consideration.

36233

the veteran receiving a cumulative equivalent dose of at least 0.05 Sievert of ionising radiation to the site affected by soft tissue sarcoma from internal deposition of a substance which emits alpha particles at least two years before the clinical onset of the condition under consideration, on operational service, was due to the veteran's serious default, wilful act or serious breach of discipline.

or

36226

the veteran received ionising radiation to the site affected by soft tissue sarcoma from internal deposition of a substance which emits alpha particles due to an illness or injury which is identifiable.

36227 as a consequence of the identified illness or injury, the veteran received a cumulative equivalent dose of at least 0.05 Sievert of ionising radiation to the site affected by soft tissue sarcoma from internal deposition of a substance which emits alpha particles.

36231

as a consequence of the identified illness or injury, the veteran received a cumulative equivalent dose of at least 0.05 Sievert of ionising radiation to the site affected by soft tissue sarcoma from internal deposition of a substance which emits alpha particles at least two years before the clinical onset of the condition under consideration.

36229 — the identified illness or injury, as a consequence of which the veteran received a cumulative equivalent dose of at least 0.05 Sievert of ionising radiation to the site affected by soft tissue sarcoma from internal deposition of a substance which emits alpha particles, is causally related to operational service.

Clinical onset and eligible service [36216]

36221

on eligible service, the veteran received a cumulative equivalent dose of at least 0.5 Sievert of ionising radiation to the site affected by soft tissue sarcoma from internal deposition of a substance which emits alpha particles.

36223

as a causal result of eligible service, the veteran received a cumulative equivalent dose of at least 0.5 Sievert of ionising radiation to the site affected by soft tissue sarcoma from internal deposition of a substance which emits alpha particles.

36225

as a causal result of eligible service, the veteran received a cumulative equivalent dose of at least 0.5 Sievert of ionising radiation to the site affected by soft tissue sarcoma from internal deposition of a substance which emits alpha particles at least five years before the clinical onset of the condition under consideration.

36234

the veteran receiving a cumulative equivalent dose of at least 0.5 Sievert of ionising radiation to the site affected by soft tissue sarcoma from internal deposition of a substance which emits alpha particles at least five years before the clinical onset of the condition under consideration, on eligible service, was due to the veteran's serious default, wilful act or serious breach of discipline.

or

36226

the veteran received ionising radiation to the site affected by soft tissue sarcoma from internal deposition of a substance which emits alpha particles due to an illness or injury which is identifiable.

36228 as a consequence of the identified illness or injury, the veteran received a cumulative equivalent dose of at least 0.5 Sievert of ionising radiation to the site affected by soft tissue sarcoma from internal deposition of a substance which emits alpha particles.

36232

as a consequence of the identified illness or injury, the veteran received a cumulative equivalent dose of at least 0.5 Sievert of ionising radiation to the site affected by soft tissue sarcoma from internal deposition of a substance which emits alpha particles at least five years before the clinical onset of the condition under consideration.

36230 — the identified illness or injury, as a consequence of which the veteran received a cumulative equivalent dose of at least 0.5 Sievert of ionising radiation to the site affected by soft tissue sarcoma from internal deposition of a substance which emits alpha particles, is causally related to eligible service.